or Try an Advanced Search...

    Technical Analysis for PROC - Procaps Group, S.A.

    Grade Last Price % Change Price Change
    D 2.71 0.37% 0.01
    PROC closed up 0.37 percent on Friday, April 19, 2024, on 5 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical PROC trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Up 3 Days in a Row Strength 0.00%
    MACD Bullish Signal Line Cross Bullish 0.37%
    Stochastic Buy Signal Bullish 0.37%
    Pocket Pivot Bullish Swing Setup 0.37%
    Narrow Range Bar Range Contraction 0.37%
    Inside Day Range Contraction 0.37%
    Oversold Stochastic Weakness 0.37%
    20 DMA Resistance Bearish 1.12%
    Wide Range Bar Range Expansion 1.12%
    Older End-of-Day Signals for PROC ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 19 hours ago
    Possible Inside Day 2 days ago
    Rose Above 10 DMA 2 days ago
    Possible Pocket Pivot 2 days ago
    Gap Up Closed 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PROC Chart by TradingView
    Basic chart:

    Profile

    Procaps is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in Latin America and, as of December 31, 2020, had more than 4,700 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Health Sciences Drugs Pharmacy Medication Dietary Supplement Prescription Drugs Clinical Pharmacology Nutraceutical Over The Counter Drug

    Is PROC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 13 Procaps Group S.A. (NASDAQ:PROC) insiders have significant skin in the game with 60% ownership
    Mar 4 Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives
    Dec 27 Pharma Company Procaps Beats On Q3 But Lowers FY23 Guidance: Here's Why
    Dec 27 Coherus BioSciences, Ascent Industries And 3 Stocks To Watch Heading Into Wednesday
    Dec 27 Procaps Group reports Q3 results; updates FY23 outlook
    Dec 26 Procaps Group Reports Third Quarter 2023 Results
    Dec 21 Statement from the Board of Directors of Procaps Group
    Nov 22 Procaps Group says CEO Minski to step down from the role
    Nov 22 Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024
    Nov 14 Procaps Group Update on Third Quarter Results
    See more PROC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.38
    52 Week Low 1.95
    Average Volume 14,623
    200-Day Moving Average 3.41
    50-Day Moving Average 3.04
    20-Day Moving Average 2.78
    10-Day Moving Average 2.65
    Average True Range 0.14
    RSI (14) 42.53
    ADX 20.74
    +DI 33.38
    -DI 30.23
    Chandelier Exit (Long, 3 ATRs) 2.76
    Chandelier Exit (Short, 3 ATRs) 2.96
    Upper Bollinger Bands 3.07
    Lower Bollinger Band 2.48
    Percent B (%b) 0.39
    BandWidth 21.09
    MACD Line -0.13
    MACD Signal Line -0.14
    MACD Histogram 0.0139
    Fundamentals Value
    Market Cap 305.75 Million
    Num Shares 113 Million
    EPS 0.51
    Price-to-Earnings (P/E) Ratio 5.31
    Price-to-Sales 0.89
    Price-to-Book 9.71
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.71
    Resistance 3 (R3) 2.71 2.71 2.71
    Resistance 2 (R2) 2.71 2.71 2.71 2.71
    Resistance 1 (R1) 2.71 2.71 2.71 2.71 2.71
    Pivot Point 2.71 2.71 2.71 2.71 2.71
    Support 1 (S1) 2.71 2.71 2.71 2.71 2.71
    Support 2 (S2) 2.71 2.71 2.71 2.71
    Support 3 (S3) 2.71 2.71 2.71
    Support 4 (S4) 2.71